Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
SNT Announcements
Positive FDA feedback for Amsulostat…
SNT
SYNTARA LIMITED
Market sensitive
Positive FDA feedback for Amsulostat P2b trial
Date and time
28 April 2026 at 10:06 pm
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
SNT announcement history
Recent SNT announcements
Investor Update Webinar Presentation
Investor Update Webinar
Investor Presentation
Quarterly Activities/Appendix 4C Cash Flow Report
AZALOX MDS study advances to final Phase 1b cohort
SNT-4728 Webinar Presentation